Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
27.91
-0.26 (-0.92%)
At close: Mar 5, 2026, 4:00 PM EST
27.91
0.00 (0.00%)
After-hours: Mar 5, 2026, 4:10 PM EST

Castle Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
8301,1557595926251,088
Market Cap Growth
8.97%52.13%28.33%-5.37%-42.55%-34.70%
Enterprise Value
567.31892.21492.29363.76379.76766.42
Last Close Price
27.9138.9026.6521.5823.5442.87
PE Ratio
--46.8742.98-10.08-9.12-34.57
PS Ratio
2.413.352.292.694.5611.56
PB Ratio
1.762.451.671.511.572.64
P/TBV Ratio
1.722.401.711.481.542.62
P/FCF Ratio
29.2940.7720.77-30.73-13.22-48.43
P/OCF Ratio
12.9017.9511.70-105.14-15.01-57.31
EV/Sales Ratio
1.652.591.481.662.778.15
EV/EBITDA Ratio
--437.5719.96-6.54-6.09-20.90
EV/EBIT Ratio
--20.8456.78-5.35-5.21-19.12
EV/FCF Ratio
20.0331.5013.47-18.90-8.03-34.11
Debt / Equity Ratio
0.080.080.060.040.030.02
Debt / EBITDA Ratio
-18.10-18.101.07-0.28-0.21-0.22
Debt / FCF Ratio
1.301.300.72-0.80-0.28-0.36
Net Debt / Equity Ratio
-0.56-0.56-0.58-0.58-0.61-0.78
Net Debt / EBITDA Ratio
128.79128.79-10.824.093.948.77
Net Debt / FCF Ratio
-9.27-9.27-7.3011.835.1914.31
Asset Turnover
0.620.620.670.490.300.21
Inventory Turnover
7.737.737.497.5510.677.47
Quick Ratio
4.994.996.975.907.8113.94
Current Ratio
5.265.267.296.208.0914.21
Return on Equity (ROE)
-6.26%-5.24%4.31%-14.54%-16.56%-11.78%
Return on Assets (ROA)
-7.54%-6.32%1.49%-15.12%-15.60%-10.82%
Return on Invested Capital (ROIC)
-20.71%-17.38%4.14%-42.82%-53.86%-76.57%
Return on Capital Employed (ROCE)
-8.63%-8.63%1.95%-16.64%-17.16%-9.36%
Earnings Yield
-2.91%-2.13%2.33%-9.92%-10.96%-2.89%
FCF Yield
3.41%2.45%4.81%-3.25%-7.57%-2.06%
Buyback Yield / Dilution
0.61%0.61%0.50%0.36%-0.26%-0.50%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q